{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T17:46:22Z","timestamp":1757699182264},"reference-count":28,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3892,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> Autoimmunity may be observed in chronic viral hepatitis, in particular hepatitis C and D. The hepatitis C virus (HCV) displays numerous interactions with the immune system. Hepatitis C virus induces a number of diseases of presumed autoimmune background, like mixed cryoglobulinaemia, glomerulonephritis, panarthritis, arthritis, thyroiditis and skin lesions. On the other hand a number of autoantibodies are observed during the course of hepatitis C, Of particular interest are liver\/kidney microsomal antibodies (LKM). Their occurrence in viral hepatitis may indicate an increased risk for treatment with interferons. LKM antibodies in chronic hepatitis C recognize several autoepitopes differing from those in autoimmune hepatitis. Hepatitis C\u2010associated LKM antibodies are more heterogeneous. They recognize either conformational or several distinct linear autoepitopes on cytochrome P450 2D6; they may also react with other microsomal proteins. Apart from their molecular weight at 59 and 70 kDa these microsomal antigens are not yet identified. Another model of virus\u2010induced autoimmunity in man is chronic hepatitis D which always requires co\u2010infection with hepatitis B. Hepatitis D is known to be associated with a number of autoantibodies, amongst them LKM\u20103. LKM\u20103 antibodies have recently been shown to react with proteins of the UDP glucuronosyl\u2010transferase family (UGT). The main antigen is an autoepitope expressed on exon 2\u20135 of family 1 UGTs. Some hepatitis D sera recognize a minor second epitope on family 2 UGTs. It is interesting that hepatitis C patients recognize proteins of the cytochrome P450 family while hepatitis D sera react with UGTs. There seems to be little overlap between autoimmunity seen in hepatitis C and D as far as autoepitopes are concerned. LKM\u20103 antibodies against UGT 1 are also seen in a minority of patients with autoimmune hepatitis type 2. However, the autoimmune response against UGTs seen in autoimmune hepatitis differs from that observed in viral hepatitis. Autoantibodies in autoimmune liver disease are usually more homogenous and are directed against precise linear epitopes. Autoepitopes in autoimmune hepatitis usually represent conserved regions of these proteins, the antibody usually is inhibitory and antibody litres are very high. In contrast, autoantibodies in viral hepatitis are more heterogenous, recognize several linear and conformational epitopes: antibody titres are much lower. However, the major LKM autoantigen in chronic hepatitis C also is P450 2D6. Autoimmune hepatitis and autoimmmunity in viral hepatitis must be distinguished clinically by all means due to the need for specific therapeutic interventions. These liver diseases may serve as models to study virus induced autoimmunity and autoimmune disease in man.<\/jats:p>","DOI":"10.1111\/j.1365-2893.1997.tb00179.x","type":"journal-article","created":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T10:43:37Z","timestamp":1207565017000},"page":"42-47","source":"Crossref","is-referenced-by-count":31,"title":["Viral induction of autoimmunity: mechanisms and examples in hepatology"],"prefix":"10.1111","volume":"4","author":[{"given":"M. P.","family":"Manns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Obermayer\u2010Straub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92858-Y"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91438-2"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115443"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90074-8"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/0016-5085(93)90657-X","article-title":"Characterisation of anti\u2010liver\u2010kidney microsome antobody (anti\u2010LKM1) from hepatitis C virus\u2010positive and \u2010negative sera","volume":"104","author":"Yamamoto AM","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_1_7_2","first-page":"235A","article-title":"A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis Type\u20102 and chronic hepatitis C virus infection: a sensitive and quantitative radiologic assay","volume":"24","author":"Yamamoto AM","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_1_8_2","article-title":"Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney micorsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection","author":"Ma Y.","journal-title":"J Hepatol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240619"},{"key":"e_1_2_1_10_2","first-page":"4","article-title":"The target antigen of liver kidney microsomal antibody is different in type 2 autoimmune chronic active hepatitis and chronic hepatitis C virus infection","volume":"16","author":"Ma Y.","year":"1992","journal-title":"J Hepatol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90417-0"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80201-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80395-2"},{"key":"e_1_2_1_14_2","first-page":"1400","article-title":"Non\u2010A, non\u2010B hepatitis specific antibodies directed at host derived epitope: implication for an autoimmune process","author":"Michiro S.","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91332-3"},{"key":"e_1_2_1_16_2","first-page":"300","article-title":"Patterns of immune responses to the host encoded GOR and hepatitis C virus core\u2010derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity","volume":"173","author":"Quiroga JA","year":"1996","journal-title":"J Clin Invest"},{"key":"e_1_2_1_17_2","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (\u03b4) agent","volume":"54","author":"Crivelli O.","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91966-6"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)29009-5"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.2.551"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118936"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1996.0415"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114660"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006283222601"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","unstructured":"SmithBR FumaraniakJ.Editorial: Adrenal and autoimmune diseases.J Clin Endocrin Metab1995;1502\u20131505.","DOI":"10.1210\/jcem.80.5.7744992"},{"issue":"1","key":"e_1_2_1_26_2","first-page":"126","article-title":"Cytochrome P450 1A2 as the hepatocellular autoantigen in autoimmune polyendocrine syndrome type 1","volume":"23","author":"Clemente MG","year":"1995","journal-title":"J Hepatol"},{"key":"e_1_2_1_27_2","first-page":"233A","article-title":"Cytochrome P450 2A6: A new autoantigen in autoimmune liver disease","volume":"24","author":"Clemente MG","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_1_28_2","first-page":"234A","article-title":"Different liver cytochromes P450 are autoantigens in hepatitis patients with autoimmune hepatitis and with autoimmune polyglandular syndrome type 1 (APS\u20101)","volume":"24","author":"Obermayer\u2010Straub P.","year":"1996","journal-title":"Hepatology"},{"key":"e_1_2_1_29_2","unstructured":"ChoudhuryK. GregorioGV Mieli\u2010VerganiG. VerganiD.Structural similarity and humoral cross\u2010reactivity in target antigens of organ\u2010specific autoimmune disease.Proceedings of the 29th Annual Meeting and Postgraduate Training Course of the European Society for Paediatric Gastroenterology and Nutrition in Munich 1996:79."}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.1997.tb00179.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2893.1997.tb00179.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:49:02Z","timestamp":1695811742000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.1997.tb00179.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":28,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1111\/j.1365-2893.1997.tb00179.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.1997.tb00179.x","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}